Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Toward a genetic analysis of tumor rejection antigens.

× No keyword cloud information.

24 in total

Review 1. VEGF as a mediator of tumor-associated immunodeficiency.

Authors: J E Ohm; D P Carbone
Journal: Immunol Res Date: 2001 Impact factor: 2.829

Review 2. Reflections on human tumor immunology.

Authors: E Klein
Journal: Med Oncol Tumor Pharmacother Date: 1993

3. Adenovirus-mediated gene transfer of B7.1 induces immunological anti-tumor effects in a murine brain tumor.

Authors: Jun Morioka; Koji Kajiwara; Koichi Yoshikawa; Makoto Ideguchi; Tetsuya Uchida; Yoshinori Ohmoto; Michiyasu Suzuki
Journal: J Neurooncol Date: 2002-10 Impact factor: 4.130

4. Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas.

Authors: K B Quattrocchi; C H Miller; S Cush; S A Bernard; S T Dull; M Smith; S Gudeman; M A Varia
Journal: J Neurooncol Date: 1999 Impact factor: 4.130

Review 5. The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors--lessons from normal and immunodeficient mice.

Authors: I M Svane; M Boesen; A M Engel
Journal: Med Oncol Date: 1999-12 Impact factor: 3.064

6. HL-60 myeloid leukaemia cells acquire immunostimulatory capability upon treatment with retinoic acid: analysis of the responding population and mechanism of cytotoxic lymphocyte activation.

Authors: S M Geary; L K Ashman
Journal: Immunology Date: 1996-07 Impact factor: 7.397

7. Major histocompatibility complex-restricted recognition of autologous chronic lymphocytic leukemia by tumor-specific T cells.

Authors: W Sherman; Z Liu; G Inghirami; E F Reed; P E Harris; N M Suciu-Foca
Journal: Immunol Res Date: 1993 Impact factor: 2.829

8. Cytotoxic susceptibility and defective MHC class I expression do not correlate with mutation of p53 in human carcinomas.

Authors: Z Végh; P Wang; F Vánky; C Hising; K Sjöwall; B Larsson; E Klein
Journal: Cancer Immunol Immunother Date: 1994-01 Impact factor: 6.968

9. Immunodominant minor histocompatibility antigens expressed by mouse leukemic cells can serve as effective targets for T cell immunotherapy.

Authors: S Pion; P Fontaine; C Baron; M Gyger; C Perreault
Journal: J Clin Invest Date: 1995-04 Impact factor: 14.808

Review 10. Mechanisms of action of bacillus Calmette-Guérin in the treatment of superficial bladder cancer.

Authors: J J Patard; D K Chopin; L Boccon-Gibod
Journal: World J Urol Date: 1993 Impact factor: 4.226